학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 17건 | 목록 1~20
Academic Journal
LEUKEMIA RESEARCH
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
instname
Leukemia Research, 67, pp. 21-26
de Swart, L, Smith, A, Haase, D, Fenaux, P, Symeonidis, A, Cermak, J, Sanz, G, Stauder, R, Mittelman, M, Hellström-Lindberg, E, Malcovati, L, Langemeijer, S, Skov-Holm, M, Mądry, K, Germing, U, Almeida, A M, Tatic, A, Savic, A, Šimec, N G, van Marrewijk, C, Guerci-Bresler, A, Sanhes, L, Luño, E, Culligan, D, Beyne-Rauzy, O, Burgstaller, S, Blijlevens, N, Bowen, D & de Witte, T 2018, 'Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS', Leukemia Research, vol. 67, pp. 21-26. https://doi.org/10.1016/j.leukres.2018.01.022
Academic Journal
Haematologica
HAEMATOLOGICA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
instname
Haematologica, Vol 105, Iss 3 (2020)
Hoeks, M, Yu, G, Langemeijer, S, Crouch, S, de Swart, L, Fenaux, P, Symeonidis, A, Čermák, J, Hellström-Lindberg, E, Sanz, G, Stauder, R, Holm, M S, Mittelman, M, Mądry, K, Malcovati, L, Tatic, A, Almeida, A M, Germing, U, Savic, A, Gredelj Šimec, N, Culligan, D, Itzykson, R, Guerci-Bresler, A, Slama, B, van de Loosdrecht, A, van Marrewijk, C, Droste, J, Blijlevens, N, van Kraaij, M, Bowen, D, de Witte, T, Smith, A & EUMDS Registry Participants 2020, 'Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry', Haematologica, vol. 105, no. 3, pp. 640-651. https://doi.org/10.3324/haematol.2018.212332
Haematologica, 105, 3, pp. 640-651
Hoeks, M, Yu, G, Langemeijer, S, Crouch, S, de Swart, L, Fenaux, P, Symeonidis, A, Čermák, J, Hellström-Lindberg, E, Sanz, G, Stauder, R, Holm, M S, Mittelman, M, Mądry, K, Malcovati, L, Tatic, A, Almeida, A M, Germing, U, Savic, A, Šimec, N G, Culligan, D, Itzykson, R, Guerci-Bresler, A, Slama, B, van de Loosdrecht, A, van Marrewijk, C, Droste, J, Blijlevens, N, van Kraaij, M, Bowen, D, de Witte, T & Smith, A 2020, 'Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry', Haematologica, vol. 105, no. 3, pp. 640-651. https://doi.org/10.3324/haematol.2018.212332
Academic Journal
De Witte T; Department of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, Nijmegen; TdW and LM both contributed equally as co-first authors. theo.dewitte@radboudumc.nl.; Malcovati L; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia; TdW and LM both contributed equally as co-first authors. theo.dewitte@radboudumc.nl.; Fenaux P; Service d'Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Paris. theo.dewitte@radboudumc.nl.; Bowen D; St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds. theo.dewitte@radboudumc.nl.; Symeonidis A; Department of Medicine, Division of Hematology, University of Patras Medical School, Patras. theo.dewitte@radboudumc.nl.; Mittelman M; Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty, Tel Aviv University, Tel Aviv. theo.dewitte@radboudumc.nl.; Stauder R; Department of Internal Medicine V (Haematology and Oncology), Innsbruck Medical University, Innsbruck. theo.dewitte@radboudumc.nl.; Sanz G; Department of Haematology, Hospital Universitario y Politécnico La Fe, Valencia, and CIBERONC, Madrid. theo.dewitte@radboudumc.nl.; Čermák J; Department of Clinical Hematology, Inst. of Hematology and Blood Transfusion, Praha. theo.dewitte@radboudumc.nl.; Langemeijer S; Department of Hematology, Radboud University Medical Center, Nijmegen. theo.dewitte@radboudumc.nl.; Hellström-Lindberg E; Department of Medicine, Division Hematology, Karolinska Institutet, Stockholm. theo.dewitte@radboudumc.nl.; Germing U; Department of Haematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Düsseldorf. theo.dewitte@radboudumc.nl.; Skov Holm M; Department of Haematology, Aarhus University Hospital, Aarhus. theo.dewitte@radboudumc.nl.; Mądry K; Department of Haematology, Oncology and Internal Medicine, Warszawa Medical University, Warszawa. theo.dewitte@radboudumc.nl.; Tatic A; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest. theo.dewitte@radboudumc.nl.; Medina Almeida A; Department of Clinical Hematology, Hospital da Luz, Lisbon. theo.dewitte@radboudumc.nl.; Savic A; Clinic of Hematology - Clinical Center of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad. theo.dewitte@radboudumc.nl.; Mandac Rogulj I; Department of Internal Medicine, Division of Hematology, Merkur University Hospital, Zagreb. theo.dewitte@radboudumc.nl.; Itzykson R; Service d'Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Paris. theo.dewitte@radboudumc.nl.; Hoeks M; Department of Hematology, Radboud University Medical Center, Nijmegen. theo.dewitte@radboudumc.nl.; Gravdahl Garelius H; Department of Specialist Medicine, Sahlgrenska University Hospital, Göteborg. theo.dewitte@radboudumc.nl.; Culligan D; Department of Haematology, Aberdeen Royal Infirmary, Aberdeen. theo.dewitte@radboudumc.nl.; Kotsianidis I; Department of Hematology, Democritus University of Thrace Medical School, University Hospital of Alexandroupolis, Alexandroupolis. theo.dewitte@radboudumc.nl.; Ades L; Service d'Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Paris. theo.dewitte@radboudumc.nl.; Van de Loosdrecht AA; Department of Hematology - Cancer Center Amsterdam, Amsterdam UMC, Location VU University Medical Center, Amsterdam. theo.dewitte@radboudumc.nl.; Van Marrewijk C; Department of Hematology, Radboud University Medical Center, Nijmegen. theo.dewitte@radboudumc.nl.; Yu G; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York. theo.dewitte@radboudumc.nl.; Crouch S; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York. theo.dewitte@radboudumc.nl.; Smith A; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York. theo.dewitte@radboudumc.nl.
Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Academic Journal
Malcovati L; Department of Hematology and Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo, and.; Hellström-Lindberg EBowen DAdès LCermak JDel Cañizo CDella Porta MGFenaux PGattermann NGerming UJansen JHMittelman MMufti GPlatzbecker USanz GFSelleslag DSkov-Holm MStauder RSymeonidis Avan de Loosdrecht AAde Witte TCazzola M
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Skov-Holm, M
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어